| Application no. and date | 14874617.5 (espacenet) (Federated) (European Patent Register), 20141223 | | Patent/reg. no. and date | DK/EP 3086793, 20220511 | | Publication date | 20161102 | | Priority no. and date | US 201361920617 P, 20131224 | | EP pub. no. and date |
EP 3086793 20161102 | | Effective date | | | Applicant/owner | Durect Corporation, 10260 Bubb Road
Cupertino, CA 95014, US,
Virginia Commonwealth University, 800 East Leigh Street
Suite 3000
Richmond, VA 23298, US,
The United States Government as Represented by the
Department of Veterans Affairs, 810 Vermont Avenue, N.W.
Washington, DC 20420, US | | Applicant ref. no. | V446354DK00 | | Inventor | THEEUWES, Felix, 27350 Altamont Road
Los Altos Hills, CA 94022, US,
Brown, James E., 126 Blueberry Hill Drive
Los Gatos, CA 95032, US,
REN, Shunlin, 1201 Broad Rock Blvd.
Research 151
Richmond, VA 23249, US,
LIN, WeiQi, 590 California Way
Emerald Hills, VA 94062, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/56 (2006.01) , A61K 31/568 (2006.01) , A61K 31/575 (2006.01) , A61K 35/12 (2015.01) , A61P 1/16 (2006.01) , A61P 13/12 (2006.01) , A61P 43/00 (2006.01) | | Title | Anvendelse af oxygenerede cholesterolsulfater (ocs) til behandling af nyredysfunktion | | Int. application no. | US2014072128 | | Int. publication no. | WO2015100312 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
